Background illustration for clinical trials search

Paid Clinical Trials Salem

Discover 955 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

SW-682 in Advanced Solid Tumors

for
Advanced Solid Tumor, Mesothelioma, Malignant
Location: Portland OR, Sacramento CA, Santa Monica CA,
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany

Sex: All

Age: 18+

Code: NCT06251310

Phase 1, Recruiting

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Portland OR, San Francisco CA, Las Vegas NV,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18+

Code: NCT07032662

Phase 2, Recruiting

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

for
NSCLC (Non-small Cell Lung Cancer), HNSCC, Endometrial,
Location: Portland OR, Maumee OH, Fairfax VA
Sponsor: TwoStep Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07814248

Phase 1, Recruiting

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Portland OR, Santa Monica CA, Phoenix AZ, Denver CO,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03972657

Phase 1, Phase 2, Recruiting

Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE

for
Prostate Carcinoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06011499

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

for
Acute Monocytic Leukemia, Acute Myeloid Leukemia
Location: Portland OR, Miami FL
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06504459

Phase 2, Recruiting

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

for
Atrial Fibrillation, Esophageal Carcinoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06067438

Phase 2, Recruiting

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

for
Locally Advanced Pancreatic Ductal Adenocarcinoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT04005690

Early Phase 1, Recruiting

Use Of Indocyanine Green In Pancreas Surgery

for
Pancreatic Carcinoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06084013

Recruiting

Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study

for
Chronic Graft-versus-Host-Disease, Leukemia,
Location: Portland OR, Vancouver, San Francisco CA, Calgary,
Sponsor: University of British Columbia

Sex: All

Age: 0 - 24

Code: NCT04372524

Recruiting

EMBRACE: Exercising Together

for
Breast Carcinoma, Prostate Carcinoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06049355

Phase 2, Recruiting

Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia

for
Acute Myeloid Leukemia
Location: Portland OR, Dallas TX
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT04659616

Phase 1, Recruiting

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

for
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8,
Location: Portland OR, Seattle WA
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT05081024

Recruiting

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

for
Non Hodgkin Lymphoma,
Location: Portland OR, Stanford CA, Gilbert AZ, Westwood KS,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT06116110

Recruiting

IVIG for Infection Prevention After CAR-T-Cell Therapy

for
Hematologic Malignancies
Location: Portland OR, Seattle WA, Duarte CA, New York NY,
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT05952804

Phase 2, Recruiting

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

for
Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18 - 70+

Code: NCT06249191

Phase 1, Phase 2, Recruiting

Feasibility of FMISO in Brain Tumors

for
IDH Wild Type Glioblastoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT03649880

Phase 2, Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Portland OR, Seattle WA, Vancouver, San Francisco CA,
Sponsor: Corvus Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06561048

Phase 3, Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

for
Urinary Bladder Neoplasms,
Location: Portland OR, Seattle WA, Bakersfield CA, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06833073

Phase 2, Recruiting

Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia

for
Acute Myeloid Leukemia,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06357182

Phase 1, Recruiting